PolyMedix, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.polymedix.com
Clinical Trials
3
Active:1
Completed:1
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Reversal of Heparin in Patients Undergoing Percutaneous Coronary Intervention (PCI)
Phase 2
Terminated
- Conditions
- Percutaneous Coronary InterventionCoronary Artery Disease (CAD)Angioplasty
- Interventions
- First Posted Date
- 2011-03-11
- Last Posted Date
- 2012-05-17
- Lead Sponsor
- PolyMedix, Inc.
- Target Recruit Count
- 17
- Registration Number
- NCT01312935
Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus
Phase 2
Completed
- Conditions
- Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA)(Susceptible or Methicillin Resistant)
- Interventions
- Drug: PMX-30063-investigational drug
- First Posted Date
- 2010-09-29
- Last Posted Date
- 2012-05-17
- Lead Sponsor
- PolyMedix, Inc.
- Target Recruit Count
- 215
- Registration Number
- NCT01211470
- Locations
- 🇷🇺
11 Sites, Multiple, Russian Federation
🇺🇦5 Sites, Multiple, Ukraine
News
No news found